# Agência Nacional de Vigilância Sanitária

Source: https://onco.cc/institutions/anvisa/  
OnCo record `anvisa` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

ANVISA registers medicines in Brazil, Latin America's largest market, and joined the FDA's Project Orbis in 2019; public coverage is decided separately by CONITEC, so the gap between ANVISA registration and availability in the public system is a central issue in Brazilian oncology.

## Summary

Created in 1999, ANVISA regulates medicines, devices, food, cosmetics and tobacco in Brazil and registers new drugs before they can be sold or considered for the public health system. It joined the FDA's Project Orbis in 2019, has adopted reliance and priority review pathways for oncology drugs, and is an ICH member. Coverage in the public Sistema Único de Saúde is decided separately by CONITEC, which conducts health technology assessment, while private insurers follow the ANS list; the gap between ANVISA registration and public availability is a central issue in Brazilian oncology. ANVISA's tobacco regulation includes some of the world's earliest bans on flavoured cigarettes.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- Also known as: ANVISA; Brazilian Health Regulatory Agency
- City: Brasília, BR
- Type: government
- Website: https://www.gov.br/anvisa

## Sources

- ANVISA: https://www.gov.br/anvisa

## Connected records

- institutions: [Comisión Federal para la Protección contra Riesgos Sanitarios](https://onco.cc/institutions/cofepris/), [FDA Oncology Center of Excellence](https://onco.cc/institutions/fda-oce/), [Hospital Israelita Albert Einstein](https://onco.cc/institutions/einstein-sao-paulo/), [Hospital Sírio-Libanês](https://onco.cc/institutions/sirio-libanes/)
- people: [Carlos Barrios](https://onco.cc/people/barrios-carlos/), [Leandro Pinheiro Safatle](https://onco.cc/people/leandro-pinheiro-safatle/), [Paulo Hoff](https://onco.cc/people/hoff-paulo/)
- bottlenecks: [Most of the world has almost no cancer care](https://onco.cc/bottlenecks/b-global-access/), [Regulatory divergence between regions](https://onco.cc/bottlenecks/b-regulatory-fragmentation/)

---
JSON: https://onco.cc/api/v1/entities/anvisa.json